Description
Description
Tirzepatide (20mg) is a research-grade dual agonist targeting both GIP and GLP-1 receptors. It is utilized to investigate the complex interactions between incretin hormones and metabolic health.
Research Applications
Studies explore the efficacy of dual receptor targeting on glucose metabolism and weight regulation pathways.
Reviews
There are no reviews yet.